SCHEMBL6508245

SCHEMBL6508245

CCN(Cc1cncc(-c2ccc3c(c2)c(-c2ncc(C(=O)NC4CCCCC4)[nH]2)nn3C2CCCCO2)c1C)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.35
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
RXRG P48443 1/20 0.32
TSHR P16473 1/20 0.32
TP53 P04637 2/20 0.31
KDM4E B2RXH2 3/20 0.31
ALDH1A1 P00352 3/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
MAPT P10636 1/20 0.31
HSD17B10 Q99714 2/20 0.31
PPARG P37231 1/20 0.31
WNT1 P04628 1/20 0.31
DYRK1A Q13627 1/20 0.31
CYP4F2 P78329 1/20 0.30
CYP4A11 Q02928 1/20 0.30
ATR Q13535 1/20 0.30
MEN1 O00255 1/20 0.30
GAA P10253 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6508214 0.93 ATR (0.34) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL6508925 0.92 RXRA (0.32) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL6510250 0.92 RXRA (0.31) RAB9ARXRARXRBRXRGPPARG
SCHEMBL6506708 0.92 RXRA (0.31) RXRARXRBRXRGATR
SCHEMBL6508778 0.91 CYP4F2 (0.33) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL6510234 0.91 RAB9A (0.32) RAB9ATSHRATR
SCHEMBL6510723 0.91 CNR2 (0.31) RXRARXRBRXRGCNR2
SCHEMBL6508954 0.89 MAP3K8 (0.31) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL6507048 0.89 MAP3K8 (0.31) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL6505088 0.89 ALDH1A1 (0.38) TP53KDM4EALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050090529-A1 3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation PFIZER INC 2005-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090529-A1 3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation CDK3, CDK4, CDK9 RAB9A 1938/4885RXRA 2748/4885RXRB 2441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.